History
Hypothyroidism refers to a condition in which the thyroid hormone produced by the thyroid gland becomes deficient, so that many functions of the body slow down overall. The history of this disease is close to "a process of first recognizing the symptoms and only later finding the cause." In the 19th century, a characteristic condition was observed in which the face and limbs swelled, the skin thickened, speech and movement slowed, and people became sensitive to cold, and this began to be called myxedema. At the time the cause was not clear, but as it later became known that similar symptoms appeared in people whose thyroid had been surgically removed, a clue emerged that the thyroid was at the center of these symptoms.
In the 1890s, treatment by injecting or feeding extracts made from animal thyroid tissue was attempted. As experience accumulated that "supplementing what is lacking leads to improvement," this became the occasion for the concept of hormone replacement therapy to take hold. In the early 20th century, the chemical structure of thyroid hormone was identified, and as thyroxine (T4) was isolated and purified, the direction of treatment became clearer. Later, as synthetic hormone preparations began to be produced reliably, consistent and predictable treatment became possible, rather than animal-derived preparations whose effects varied unevenly from person to person.
In the 1970s, blood testing technology advanced greatly, making it possible to measure thyroid-stimulating hormone (TSH) precisely, which changed the way diagnosis and treatment adjustment are done. Levothyroxine (LT4) became firmly established as the standard treatment, and recent research also discusses that, even for the same values, the normal range and treatment goals may differ depending on age, pregnancy, and comorbidities, and that excessive medicalization should be avoided at borderline values.
Causes
The causes of hypothyroidism are easy to understand when divided into three broad branches. The first is when the thyroid itself is damaged and cannot make enough hormone. This is the most common, and in regions with sufficient iodine intake, autoimmune diseases such as Hashimoto's thyroiditis are the typical example. The term autoimmune means that the immune system mistakenly attacks "the body's own tissue" rather than external pathogens. In Hashimoto's thyroiditis, immune cells gradually damage the thyroid tissue, and over time the ability to produce thyroid hormone declines.
The second is "causes arising in the course of treatment or testing." Hypothyroidism can develop after thyroid tissue has been reduced by thyroidectomy or after the thyroid has been destroyed by radioiodine therapy. In addition, medications that affect thyroid function, such as lithium and amiodarone, and some anticancer drugs and immunotherapy agents can also be causes. Because in such cases the problem may be a side effect that arose while treating something else, it is important to check both the medications being taken and the medical history.
The third is when raw materials are lacking or the regulatory signals go wrong. Worldwide, iodine deficiency is an important cause in regions where iodine is scarce. Rarely, there is also central hypothyroidism, in which not enough TSH is released because of a problem in the pituitary gland or hypothalamus, so the thyroid is not stimulated. In congenital hypothyroidism, early detection through newborn screening and treatment can prevent serious aftereffects in most cases.
Genetic Epidemiology
Autoimmune thyroiditis, the most common form of hypothyroidism, is understood as a disease in which "genetic predisposition" and "environmental factors" act together. The risk tends to be higher in people who have family members with thyroid disease or who have other autoimmune diseases, and even within the same family, one person may progress to hypothyroidism while another may have only antibodies and maintain normal function for a long time. Such differences arise because this is not a simple structure determined by a single gene; in many cases, multiple genetic variants each raise the risk slightly, and factors such as living environment and hormonal changes are added, initiating the disease.
Gene regions that regulate the immune response are known to be repeatedly implicated. The human leukocyte antigen (HLA) region plays an important role in determining how the immune system "distinguishes self from non-self." Variants in genes related to the function of putting the brakes on immune responses, such as cytotoxic T-lymphocyte-associated antigen 4 (CTLA4), have also been reported. With such variants, the immune response may overheat more easily, or the likelihood of mistakenly attacking the body's own tissue may increase.
Recent research, through large-scale genomic studies, has established that there are a great many genetic variants that affect TSH or free thyroxine (FT4) levels, and that the "inherent normal range (individual set point)" each person has may differ. In practice, family history, thyroid autoantibodies (for example, thyroid peroxidase antibodies), and changes on repeated blood tests are more practical grounds for judgment.
General Epidemiology
Hypothyroidism is a common endocrine disease, and especially when "mild forms detected only by blood tests" are included, more people are affected than one might think. It is typically more common in women and tends to increase with age. Overt hypothyroidism refers to a state in which TSH rises while FT4 falls at the same time, so that thyroid hormone in the blood is actually deficient. In contrast, subclinical hypothyroidism is a state in which FT4 is within the normal range but only TSH is elevated. Subclinical hypothyroidism is common, but not everyone with it needs treatment.
In regions with sufficient iodine intake, Hashimoto's thyroiditis is the main cause, and a considerable number of people in the general population are positive for thyroid peroxidase antibodies. Having antibodies does not mean everyone will progress to disease, but when antibodies are present and TSH elevation persists, the risk of progressing to hypothyroidism in the future is known to be higher.
Recent research emphasizes that, especially in older adults, the "normal TSH range" may differ from that of young adults, so applying the same criteria indiscriminately can lead to overdiagnosis and overtreatment. Common symptoms such as fatigue are very common even without thyroid problems, so it is important to interpret symptoms and values together and, at borderline values, to follow the trend with repeated testing.
Pathogenesis
Thyroid hormone is close to a "speed regulator" that controls the body's metabolism. It regulates energy use and the speed of function in almost all tissues, including the heart, brain, muscles, skin, and intestines. The thyroid mainly secretes thyroxine (T4), and various tissues in the body convert it into the more potent triiodothyronine (T3) for use. T3 binds to thyroid hormone receptors (THR) in the cell nucleus to regulate gene expression, and as a result, heartbeat and body temperature maintenance, intestinal motility, concentration and mood, and the rate of skin and hair renewal are appropriately maintained.
This system is managed by a regulatory circuit called the hypothalamic–pituitary–thyroid axis. When thyrotropin-releasing hormone (TRH) is secreted in the brain, the pituitary gland makes thyroid-stimulating hormone (TSH), and TSH stimulates the thyroid to increase production of T4 and T3. Conversely, when there is enough thyroid hormone in the blood, negative feedback that reduces TRH and TSH operates to maintain balance.
The pathogenesis of hypothyroidism differs depending on the cause, but what is common to all is that "the thyroid hormone signal needed by peripheral tissues is not delivered." In Hashimoto's thyroiditis, immune cells gradually destroy thyroid tissue, reducing production itself. As these changes accumulate, the body responds by lowering its metabolic rate, and as a result, "slowing" and "stagnation" appear in many organs.
Symptoms
The symptoms of hypothyroidism can be summed up as "a feeling that the body is slowing down overall," but in reality they are very diverse and nonspecific. Typical symptoms may include fatigue, lethargy, sleepiness, a feeling of being sensitive to cold, weight gain, constipation, dry and rough skin, thinning or loss of hair, muscle and joint pain, decreased concentration, decreased memory, and mental changes such as depressed mood or anxiety. Women may experience increased menstrual flow or changes in the menstrual cycle, and for those preparing for pregnancy, it is sometimes discussed in connection with difficulty becoming pregnant or the risk of miscarriage.
The problem is that these symptoms do not appear only in hypothyroidism; they also commonly appear in a wide variety of situations, such as lack of sleep, stress, anemia, depression, chronic diseases, changes in nutritional status, and menopause. Therefore, it is difficult to confirm hypothyroidism "by symptoms alone." In subclinical hypothyroidism in particular, there may be no symptoms, or if there are, they may occur at a frequency similar to that in healthy people.
If severe hypothyroidism persists for a long time, the symptoms may become more pronounced. The voice may become hoarse and low, the face and the area around the eyes may swell, speech and movement may slow, and myxedema with thickened skin may accompany it. Although very rare, if it worsens to an extreme, it can become an emergency such as myxedema coma, with decreased consciousness, hypothermia, and depressed breathing.
Signs
Signs are changes that medical staff confirm on examination. In hypothyroidism, the skin may appear cold and dry or rough, and the face may be swollen, especially around the eyes. Bradycardia (slowing of the pulse), swelling of the hands and feet, and changes in the voice may be observed, and in some people an enlarged thyroid (goiter) can be felt at the front of the neck. In Hashimoto's thyroiditis, the thyroid may feel firm or lumpy, but this is not always the case.
A frequently mentioned feature on neurological examination is that the tendon reflexes "relax slowly." For example, when the ankle reflex is tested, the speed of return to the original position after the jerk may be slowed. In the muscles there may be weakness and muscle pain, and creatine kinase (CK) may be elevated on blood tests. In addition, blood cholesterol tends to rise, which is sometimes interpreted in connection with cardiovascular risk.
These signs can also appear in other diseases, so it is difficult to draw conclusions from signs alone. Swelling can also occur with heart or kidney problems, and dry skin is also influenced by the season and lifestyle. Therefore, signs are used as "clues that raise suspicion," and final confirmation is made with thyroid function tests. Recent research emphasizes that, because symptoms and signs are nonspecific especially with mild abnormalities in values, care is needed so that unnecessary treatment is not started because of overinterpretation.
Screening
Screening is an approach to finding, among people who have no symptoms or unclear symptoms, those who are likely to need testing. The most definitive screening test is newborn screening. In most countries, a small amount of blood is collected from the heel right after birth to measure TSH, and some programs also check T4. The purpose is to find congenital hypothyroidism as early as possible and start treatment, to prevent damage to growth and brain development.
In adults, opinions differ on whether testing should be recommended uniformly for everyone. Instead, "targeted screening" in high-risk groups is used as a realistic method. For example, in people with other autoimmune diseases, people with a family history of thyroid disease, people who have received radiation therapy to the neck area, people who have had thyroid surgery or radioiodine therapy, and people taking medications that can affect thyroid function, such as amiodarone or lithium, periodic testing can help with early detection.
The key screening test is TSH. Because TSH tends to rise when thyroid hormone becomes deficient, as the pituitary gland tries to stimulate the thyroid more strongly, it is sensitive to early changes. Recent research concludes that, because a mild TSH elevation may be temporary, it is important to confirm whether it persists by repeating the measurement after a certain period rather than drawing a conclusion from a single result.
Diagnosis
Hypothyroidism is basically diagnosed with blood tests. The most widely used diagnostic combination is TSH and free thyroxine (FT4). In general, if TSH is elevated and FT4 is decreased, overt hypothyroidism is diagnosed. If TSH is elevated but FT4 is within the normal range, it is classified as subclinical hypothyroidism. Conversely, if FT4 is low but TSH is normal or low, central hypothyroidism should be considered.
An especially important principle in diagnosis is "repeat confirmation." TSH fluctuates even within a single day, can vary slightly with the season, and may show patterns different from normal during stress or acute illness. Recent research concludes that it is not uncommon for a mild TSH elevation to return to normal without treatment, and therefore, at borderline values, an approach of retesting after 2–3 months to confirm whether the change persists is recommended.
To evaluate the cause, checking thyroid autoantibodies (for example, thyroid peroxidase antibodies) can provide information supporting Hashimoto's thyroiditis. When a lump is felt in the neck or the thyroid feels abnormal, ultrasound is used to evaluate its shape and the presence of nodules. However, not everyone needs imaging simply because "hypothyroidism is suspected"; it is chosen according to examination findings and risk level.
Treatment
The key to treating hypothyroidism is replacing the deficient hormone to return the body to a normal state. The standard treatment is steadily taking a synthetic T4 preparation called levothyroxine (LT4). Because the body converts T4 to T3 as needed, LT4 alone is sufficient for most people. In young people without heart disease, treatment can be started at a relatively full dose, but in older adults or those with heart disease such as coronary artery disease, it is safer to start with a low dose and increase it gradually.
The way the medication is taken is also very important. Absorption of LT4 can be reduced by food, coffee, calcium and iron supplements, and some antacids. Therefore, it is best to take it on an empty stomach with water whenever possible, consistently at about the same time. Because it takes time for the effect to stabilize after starting treatment or changing the dose, TSH is usually rechecked 4–8 weeks later to confirm whether the dose is appropriate. In central hypothyroidism, TSH is difficult to use as a reference, so monitoring is centered on FT4.
The treatment of subclinical hypothyroidism varies depending on the situation and is much debated. In general, treatment is considered when TSH is persistently and markedly elevated, when there is a pregnancy-related situation, or when symptoms are pronounced and the thyroid is a more convincing explanation than other causes. Recent research concludes that, especially in older adults, treating mild abnormalities in values indiscriminately can increase the risk of arrhythmia or osteoporosis due to overtreatment, so a careful approach that takes age and comorbidities into account is needed.
Prognosis
Hypothyroidism belongs to the category of "diseases that are treated relatively well once diagnosed." When LT4 is taken appropriately in overt hypothyroidism, symptoms such as fatigue, sensitivity to cold, constipation, and dry skin gradually improve, and test abnormalities such as elevated cholesterol or elevated CK also often improve over time. During pregnancy, it can affect the neurological development of the fetus and the course of pregnancy, so early diagnosis and dose adjustment are especially important. With causes that progress chronically, such as Hashimoto's thyroiditis, long-term or lifelong medication may be necessary.
"Whether the dose is appropriate" has a large effect on prognosis. If treatment is insufficient, fatigue and lethargy persist, which can also be linked to cardiovascular risk. Conversely, if overtreatment makes hormone levels excessive, discomfort such as palpitations, insomnia, and weight loss can occur, and especially in older adults, the risk of atrial fibrillation or osteoporosis can increase. When some people taking LT4 have a TSH outside the target range or their quality of life does not improve as much as expected, the way the medication is taken, drug interactions, gastrointestinal absorption problems, comorbidities, and psychological factors must be reviewed together to improve the prognosis.
Prevention
The possibility of preventing hypothyroidism differs depending on the cause. In regions where iodine deficiency is common, public health policies such as iodized salt are the most effective means of prevention. Because iodine is the raw material for thyroid hormone, keeping the intake level of the entire population above a certain level greatly helps reduce growth disorders in children, goiter, and hypothyroidism. Because iodine requirements increase during pregnancy and breastfeeding, supplementation may be considered at the discretion of medical staff in settings where it is difficult to get enough from the diet.
On the other hand, autoimmune causes such as Hashimoto's thyroiditis are difficult to prevent completely through lifestyle alone. In this case, realistic prevention is closer to "early detection in high-risk groups and prevention of complications." In people with other autoimmune diseases or a family history, people who have had past thyroid treatment, and people taking medications that can affect thyroid function, periodic thyroid function tests can catch early changes. Newborn screening is the most reliable way to prevent developmental problems caused by congenital hypothyroidism.
For people already receiving treatment, "avoiding overtreatment and undertreatment" is long-term prevention. Taking the medication regularly, having blood tests at appropriate times after dose changes, and managing the interval between the medication and supplements that interfere with absorption, such as calcium and iron supplements, can reduce unnecessary fluctuations. Recent research emphasizes that, rather than indiscriminately treating mild abnormalities in values, a strategy of accurately treating those who need it, taking age, pregnancy status, symptoms, and comorbidities into account, is important.